Latest AI and machine learning research in bipolar disorder for healthcare professionals.
Pharmacogenetics is a promising strategy to facilitate individualized care for patients with Major Depressive Disorder (MDD). Research is ongoing to identify the optimal genetic markers for predicting outcomes to antidepressant therapies. The primary aim of this systematic review was to summarize antidepressant pharmacogenetic studies to enhance understanding of the genes, variants, datatypes/meth...
BACKGROUND: Bipolar disorder (BD) is among the psychiatric disorders most prone to misdiagnosis, with both false positives and false negatives resulting in treatment delay. We employed a whole-brain machine learning approach focusing on gray matter volumes (GMVs) to contribute to defining objective biomarkers of BD and discriminating it from other forms of psychopathology, including subthreshold m...
Sarcasm is particularly notorious towards mental health, and thus it is quite essential for early identification of depressive indicators. This paper ...
Selective serotonin reuptake inhibitors (SSRIs) are widely used in depression treatment. However, the relationship between treatment efficacy and plas...
Depression is highly recurrent and heterogenous in its individual course, requiring a personalized treatment approach. Patients today can collect larg...
The contemporary diagnosis of Major Depressive Disorder (MDD) primarily relies on subjective assessments and self-reported measures, often resulting i...
Seasonal Affective Disorder (SAD) is a mood disorder characterized by recurring depressive episodes during specific seasons, particularly in Fall and ...
Hair cortisol concentration (HCC) has been theorized to reflect chronic stress, and maternal and infant HCC may be correlated due to shared genetic, p...
The selection of suitable AI models to predict disability diseases stands as a vital multi-attribute decision-making (MADM) task within healthcare tec...
Non-specific response to treatment (NSRT) is the primary contributor to the failure of randomized clinical trials in major depressive disorder (MDD). ...
Smartphone addiction (SA) significantly impacts the physical and mental health of adolescents, and can further exacerbate existing mental health issue...
The integration of chatbots into psychiatry introduces a novel approach to support clinical decision-making, but biases in their recommendations pose ...
Identifying evolutionary correspondences between cell types across species is a fundamental challenge in comparative genomics and evolutionary biolo...
BACKGROUND: Conventional approaches for major depressive disorder (MDD) screening rely on two effective but subjective paradigms: self-rated scales an...
3D Gaussian Splatting (3DGS) marks a significant milestone in balancing the quality and efficiency of differentiable rendering. However, its high ef...
Accurate prediction of lithium-ion battery capacity before material synthesis is crucial for accelerating battery material discovery. The capacity can...
Previous studies reported that opioids depress breathing by inhibiting respiratory neural networks in the brainstem. The effects of opioids on sensory...
Identifying likely placebo responders can help design more efficient clinical trials by stratifying participants, reducing sample size requirements, a...
Pain is common in middle-aged and older adults, has also been identified as a fall risk factor, whereas the mechanism of falls in pain is unclear. Thi...
Trace residual solvents in solid polymer electrolytes (SPEs) significantly affect electrolyte and interface properties, where optimal selection enhanc...